UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2023
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition
period from to
Commission File Number: 001-41143
ZALATORIS
ACQUISITION CORP.
(Exact name of registrant as specified
in its charter)
Delaware | | 86-1837862 |
State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification Number) |
99 Wall Street, Suite 5801 New York, New York | | 10005 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code:
(917) 675-3106
N/A
(Former name or former address, if
changed since last report)
Securities registered pursuant
to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Units, each consisting of one share of Class A common stock and one-half of one redeemable public warrant | | TCOA.U | | New York Stock Exchange |
Class A common stock, par value $0.0001 per share | | TCOA | | New York Stock Exchange |
Redeemable public warrants, each redeemable public whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per whole share | | TCOA.WS | | New York Stock Exchange |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒
No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 9, 2023, there were 6,358,118 shares of
Class A common stock (“Class A Common Stock”), $0.0001 par value per share, and 4,312,500 shares of Class B common stock (“Class
B Common Stock”), $0.0001 par value per share, issued and outstanding.
ZALATORIS ACQUISITION CORP.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30,
2023
TABLE OF CONTENTS
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
Zalatoris Acquisition Corp.
Condensed Balance Sheets
| |
September 30, | | |
December 31, | |
| |
2023 | | |
2022 | |
| |
(unaudited) | | |
| |
ASSETS | |
| | |
| |
Current Assets: | |
| | |
| |
Cash and cash equivalents | |
$ | 7,375 | | |
$ | 480,170 | |
Prepaid expenses | |
| 21,484 | | |
| 193,259 | |
Total Current Assets | |
| 28,859 | | |
| 673,429 | |
Cash and marketable securities held in Trust Account | |
| 68,344,713 | | |
| 176,147,094 | |
Total Assets | |
$ | 68,373,572 | | |
$ | 176,820,523 | |
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIENCY | |
| | | |
| | |
Current Liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 227,941 | | |
$ | - | |
Accrued expenses | |
| 247,565 | | |
| 123,225 | |
Income tax payable | |
| 1,056,095 | | |
| 377,989 | |
Franchise tax payable | |
| 70,000 | | |
| 16,487 | |
Excise tax payable | |
| 1,130,464 | | |
| - | |
Due to related party | |
| 816,400 | | |
| - | |
Total Current Liabilities | |
| 3,548,465 | | |
| 517,701 | |
Deferred underwriters’ discount | |
| 6,262,500 | | |
| 6,262,500 | |
Total Liabilities | |
| 9,810,965 | | |
| 6,780,201 | |
Commitments and Contingencies (Note 5) | |
| | | |
| | |
Class A common stock, $0.0001 par value; 6,358,118 and 17,250,000 shares, respectively, at a redemption value of $10.55 and $10.18 per share as of September 30, 2023 and December 31, 2022, respectively | |
| 67,090,078 | | |
| 175,640,563 | |
Stockholders’ Deficiency: | |
| | | |
| | |
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022 | |
| - | | |
| - | |
Class A common stock, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding as of September 30, 2023 and December 31, 2022 (excluding 6,358,118 and 17,250,000 Class A shares, respectively, subject to redemption as of September 30, 2023 and December 31, 2022) | |
| - | | |
| - | |
Class B common stock, $0.0001 par value; 100,000,000 shares authorized; 4,312,500 shares issued and outstanding as of September 30, 2023 and December 31, 2022 | |
| 431 | | |
| 431 | |
Additional paid-in capital | |
| - | | |
| - | |
Accumulated deficit | |
| (8,527,902 | ) | |
| (5,600,672 | ) |
Total Stockholders’ Deficiency | |
| (8,527,471 | ) | |
| (5,600,241 | ) |
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficiency | |
$ | 68,373,572 | | |
$ | 176,820,523 | |
The
accompanying notes are an integral part of these financial statements.
Zalatoris Acquisition Corp.
Condensed Statements of Operations
(unaudited)
| |
For the Three Months Ended | | |
For the Nine Months Ended | |
| |
September 30, | | |
September 30, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
Operating Expenses: | |
| | |
| | |
| | |
| |
Formation and operating costs | |
$ | 104,260 | | |
$ | 220,178 | | |
$ | 592,601 | | |
$ | 545,010 | |
Professional fees | |
| 447,241 | | |
| 138,045 | | |
| 861,229 | | |
| 356,071 | |
Franchise tax expense | |
| 50,000 | | |
| 50,000 | | |
| 150,000 | | |
| 150,000 | |
Total Operating Expenses | |
| 601,501 | | |
| 408,223 | | |
| 1,603,830 | | |
| 1,051,080 | |
Loss From Operations | |
| (601,501 | ) | |
| (408,223 | ) | |
| (1,603,830 | ) | |
| (1,051,080 | ) |
Other Income: | |
| | | |
| | | |
| | | |
| | |
Interest income | |
| 1,586,599 | | |
| 685,599 | | |
| 5,109,166 | | |
| 787,239 | |
Total Other Income | |
| 1,586,599 | | |
| 685,599 | | |
| 5,109,166 | | |
| 787,239 | |
Income (loss) before provision for income taxes | |
| 985,098 | | |
| 277,376 | | |
| 3,505,336 | | |
| (263,841 | ) |
Income tax (provision) benefit | |
| (364,433 | ) | |
| 41,929 | | |
| (1,056,138 | ) | |
| 41,929 | |
Net Income (Loss) | |
$ | 620,665 | | |
$ | 319,305 | | |
$ | 2,449,198 | | |
$ | (221,912 | ) |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted weighted average shares outstanding, Class A common stock | |
| 6,358,118 | | |
| 17,250,000 | | |
| 13,579,476 | | |
| 17,250,000 | |
Basic and diluted net income (loss) per common stock, Class A common stock | |
$ | 0.06 | | |
$ | 0.01 | | |
$ | 0.14 | | |
$ | (0.01 | ) |
Basic and diluted weighted average shares outstanding, Class B common stock | |
| 4,312,500 | | |
| 4,312,500 | | |
| 4,312,500 | | |
| 4,312,500 | |
Basic and diluted net income (loss) per common stock, Class B common stock | |
$ | 0.06 | | |
$ | 0.01 | | |
$ | 0.14 | | |
$ | (0.01 | ) |
The accompanying notes are an integral
part of these unaudited interim financial statements.
Zalatoris Acquisition Corp.
Condensed Statements of Changes in Stockholders’ Deficiency
(unaudited)
| |
For the Nine Months Ended September 30, 2023 | |
| |
| | |
| | |
Additional | | |
| | |
Total | |
| |
Class B Common Stock | | |
Paid-In | | |
Accumulated | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficiency | |
Balance - January 1, 2023 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (5,600,672 | ) | |
$ | (5,600,241 | ) |
Accretion of common stock subject to possible redemption | |
| - | | |
| - | | |
| - | | |
| (1,269,899 | ) | |
| (1,269,899 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| 943,629 | | |
| 943,629 | |
Balance - March 31, 2023 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (5,926,942 | ) | |
$ | (5,926,511 | ) |
Contribution of capital from sponsor | |
| - | | |
| - | | |
| 250,000 | | |
| - | | |
| 250,000 | |
Accretion of common stock subject to possible redemption | |
| - | | |
| - | | |
| (250,000 | ) | |
| (1,354,158 | ) | |
| (1,604,158 | ) |
Excise tax liability arising from redemption of Class A shares | |
| - | | |
| - | | |
| - | | |
| (1,124,633 | ) | |
| (1,124,633 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| 884,904 | | |
| 884,904 | |
Balance - June 30, 2023 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (7,520,829 | ) | |
$ | (7,520,398 | ) |
Accretion of common stock subject to possible redemption | |
| - | | |
| - | | |
| - | | |
| (1,621,907 | ) | |
| (1,621,907 | ) |
Excise tax liability arising from redemption of Class A shares | |
| - | | |
| - | | |
| - | | |
| (5,831 | ) | |
| (5,831 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| 620,665 | | |
| 620,665 | |
Balance - September 30, 2023 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (8,527,902 | ) | |
$ | (8,527,471 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
For the Nine Months Ended September 30, 2022 | |
| |
| | |
| | |
Additional | | |
| | |
Total | |
| |
Class B Common Stock | | |
Paid-In | | |
Accumulated | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficiency | |
Balance - January 1, 2022 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (4,478,985 | ) | |
$ | (4,478,554 | ) |
Remeasurement of Class A common stock to redemption value | |
| - | | |
| - | | |
| - | | |
| (90,122 | ) | |
| (90,122 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (341,419 | ) | |
| (341,419 | ) |
Balance - March 31, 2022 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (4,910,526 | ) | |
$ | (4,910,095 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (199,798 | ) | |
| (199,798 | ) |
Balance - June 30, 2022 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (5,110,324 | ) | |
$ | (5,109,893 | ) |
Accretion of Class A common stock subject to possible redemption | |
| - | | |
| - | | |
| - | | |
| (425,293 | ) | |
| (425,293 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| 319,305 | | |
| 319,305 | |
Balance - September 30, 2022 | |
| 4,312,500 | | |
$ | 431 | | |
$ | - | | |
$ | (5,216,312 | ) | |
$ | (5,215,881 | ) |
The accompanying notes are an integral part of these unaudited interim financial statements.
Zalatoris Acquisition
Corp.
Condensed Statements of Cash Flows
(unaudited)
| |
For the Nine Months Ended | |
| |
September 30, | |
| |
2023 | | |
2022 | |
| |
| | |
| |
Cash Flows from Operating Activities: | |
| | |
| |
Net income (loss) | |
$ | 2,449,198 | | |
$ | (221,912 | ) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| | | |
| | |
Interest earned on cash held in Trust Account | |
| (5,102,099 | ) | |
| (784,955 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 171,775 | | |
| (325,723 | ) |
Deferred tax asset | |
| - | | |
| (41,929 | ) |
Accounts payable | |
| 227,941 | | |
| (91,225 | ) |
Accrued expenses | |
| 124,339 | | |
| 155,387 | |
Income tax payable | |
| 678,106 | | |
| - | |
Franchise taxes payable | |
| 53,513 | | |
| (183,064 | ) |
Net Cash Used In Operating Activities | |
| (1,397,227 | ) | |
| (1,493,421 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Cash withdrawn from Trust Account for redemptions | |
| 113,046,448 | | |
| - | |
Proceeds from Trust Account for franchise tax reimbursement | |
| 80,000 | | |
| - | |
Proceeds from Trust Account for income tax reimbursement | |
| 378,032 | | |
| - | |
Investment of cash in Trust Account for extension payments | |
| (600,000 | ) | |
| - | |
Net Cash Provided By Investing Activities | |
| 112,904,480 | | |
| - | |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Contribution of capital from sponsor | |
| 250,000 | | |
| - | |
Payment of redemptions | |
| (113,046,448 | ) | |
| - | |
Proceeds from working capital loan from sponsor | |
| 816,400 | | |
| - | |
Proceeds from related party | |
| - | | |
| 14,775 | |
Payment of offering costs | |
| - | | |
| (335,000 | ) |
Payments to related party | |
| - | | |
| (22,557 | ) |
Proceeds from Trust Account for franchise tax reimbursement | |
| - | | |
| 257,317 | |
Net Cash Used In Financing Activities | |
| (111,980,048 | ) | |
| (85,465 | ) |
Net Decrease in Cash and Cash Equivalents | |
| (472,795 | ) | |
| (1,578,886 | ) |
Cash and Cash Equivalents - Beginning of the Period | |
| 480,170 | | |
| 2,300,375 | |
Cash and Cash Equivalents - End of the Period | |
$ | 7,375 | | |
$ | 721,489 | |
| |
| | | |
| | |
Supplemental Disclosures of Cash Flow Information: | |
| | | |
| | |
Non-cash investing and financing activities: | |
| | | |
| | |
Excise tax liability arising from redemption of Class A shares | |
$ | 1,130,464 | | |
$ | - | |
Remeasurement of Class A common stock to redemption value | |
$ | - | | |
$ | 90,122 | |
Accretion of Class A common stock subject to possible redemption | |
$ | 4,495,964 | | |
$ | 425,293 | |
The accompanying notes are an integral part of these unaudited interim financial statements.
ZALATORIS ACQUISITION CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL
STATEMENTS
Note 1 — Organization, Plan of Business Operations,
Going Concern and Management’s Plans, Risks and Uncertainties and Basis of Presentation
Organization
and Plan of Business Operations
Zalatoris Acquisition Corp. (f/k/a Trajectory Alpha Acquisition
Corp.) (the “Company”) is a blank check company incorporated in the State of Delaware on February 1, 2021. The Company was
formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization,
or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.
All activity for the period from February 1, 2021 (inception)
through September 30, 2023 relates to the Company’s formation, the IPO (as defined below) and, since the closing of the IPO, the
search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion
of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on
cash and cash equivalents from the proceeds derived from the IPO.
The Company’s sponsor is J. Streicher Holdings, LLC,
a Delaware limited liability company (the “Sponsor”). See below for details of the change in sponsor on June 2, 2023.
On December 14, 2021, the Company completed the initial
public offering (the “IPO”) of 17,250,000 units at $10.00 per unit (the “Units”), including the issuance of 2,250,000
Units as a result of the underwriter’s over-allotment option being exercised in full. Each Unit consists of one share of Class A
common stock (the “Class A Common Stock”) and one-half of one redeemable public warrant (the “Public Warrants”).
Each whole Public Warrant entitles the holder to purchase one share of Class A Common Stock at a price of $11.50 per share.
Simultaneously with the consummation
of the IPO and the full exercise of the over-allotment option by the underwriter, the Company consummated the private placement of 5,725,000
private placement warrants (the “Private Placement Warrants”) to Trajectory Alpha Sponsor LLC, the Company’s former
sponsor (the “Former Sponsor”), at a price of $1.00 per Private Placement Warrants in a private placement transaction.
Change in Sponsor
On June 2, 2023, the Company entered into a Purchase and
Contribution Agreement (the “Purchase Agreement”) with the Sponsor and the Former Sponsor, pursuant to which the Sponsor contributed
$250,000 to the Company (the “Contribution”) and paid $1.00 to the Former Sponsor (the “Consideration” and together
with the Contribution, the “Purchase Price”). In return, the Former Sponsor sold and assigned to the Sponsor 2,170,464 shares
of Class B common stock (“Class B Common Stock”) of the Company and 4,525,000 Private Placement Warrants.
In connection with the Purchase
Agreement, effective June 2, 2023, Peter Bordes, Paul Sethi, Jonathan Bond, Ninan Chacko, and Elisabeth H. DeMarse tendered their
resignations as directors of the Company, and Peter Bordes and Michael E.S. Frankel resigned as officers of the Company. Effective
June 2, 2023, Jonathan Bond, Ninan Chacko, and Elisabeth H. DeMarse also resigned as directors of the audit committee, compensation
committee, and nominating and corporate governance committee of the Company.
On June 2, 2023, in connection with the Purchase Agreement,
Pantelis Dimitriou, Niall Ennis, Paul Davis, Adeel Rouf, and Sarah Watson were appointed as members of the board of directors of the Company.
Paul Davis was appointed as Chief Executive Officer of the Company, and Pantelis Dimitriou was appointed as the Company’s Chief
Financial Officer.
In addition, on June 2, 2023, the Company entered into a Purchase
Agreement (the “Metric Assignment”) with the Sponsor, the Former Sponsor, and Metric Finance Holdings II, LLC (“Metric”),
pursuant to which the Sponsor acquired 422,434 shares of Class B Common Stock from Metric.
Accordingly, the Sponsor now holds 2,592,898 shares out of
the 4,312,500 issued and outstanding shares of Class B Common Stock and 4,525,000 Private Placement Warrants out of the 5,725,000 issued
and outstanding Private Placement Warrants.
Change of Board Member
As of July 26, 2023, Sarah Watson, who was appointed to the Company’s
board of directors June 2, 2023, stepped down from her position as a director of the Company. Ms. Watson’s resignation was not the
result of any disagreement with management or the Company on any matter relating to the Company’s operations, policies or practices.
On September 7, 2023, Ms. Watson’s vacant seat on the Board was filled by Mr. Stephanos Papadopoulos.
Extension Amendment to Amended and Restated Certificate
of Incorporation
On June 12, 2023, at a special meeting of the Company’s
stockholders (the “Special Meeting”), the stockholders of the Company approved an amendment (the “Charter Amendment”)
to the Company’s amended and restated certificate of incorporation, which amended the structure and cost of the Company’s
right to extend the date (the “Termination Date”) by which the Company must (i) consummate a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses, (ii)
cease its operations if it fails to complete such Business Combination, and (iii) redeem or repurchase 100% of the Company’s Class
A Common Stock included as part of the units sold in the Company’s initial public offering.
The Charter Amendment allows the Company to extend the Termination Date
by up to nine one-month extensions to March 14, 2024 (each one-month extension period, an “Extended Period”) provided that
if any Extended Period ends on a day that is not a business day, such Extended Period will be automatically extended to the next succeeding
business day. To obtain each one-month extension, the Company, the Sponsor, or any of their affiliates or designees must deposit into
the Company’s trust account by the deadline applicable prior to the extension the lesser of (i) $150,000 and (ii) an aggregate amount
equal to $0.04 multiplied by the number of public shares of the Company that were not redeemed in connection with the stockholder vote
at the Special Meeting (the “Extension Fee”). To date, we have caused an aggregate of $750,000 to be deposited into the trust
account for five of the nine monthly extensions such that the current termination date of the Company is November 14, 2023.
On June 26, 2023, the board of directors of the Company filed
a certificate of amendment to the amended and restated certificate of incorporation with the Secretary of State of Delaware, pursuant
to which the Company’s name was changed from “Trajectory Alpha Acquisition Corp.” to “Zalatoris Acquisition Corp.”
(the “Name Change”). This Name Change became effective as of the filing date. Trading under the new name began on June 27,
2023.
The Trust Account
The funds in the trust account will be invested only in U.S.
government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting
certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government obligations. Funds will
remain in the trust account until the earlier of (i) the consummation of its first Business Combination and (ii) the distribution of the
trust account as described below. The remaining proceeds outside the trust account may be used to pay for business, legal and accounting
due diligence on prospective acquisitions and continuing general and administrative expenses.
During the three and nine months ended September 30, 2023,
the Sponsor deposited $450,000 and $600,000, respectively, related to Extension Fees into the Company’s trust account on behalf
of the Company. Such amounts are required to be repaid by the Company to the Sponsor (a “related party”). As of September
30, 2023, the Company had recorded $600,000 of Extension Fees due to a related party on the condensed balance sheet.
Redemption of Public Shares
On June 12, 2023, the Company held a Special Meeting
where the Company’s public stockholders voted and approved a proposal to amend the Company’s Amended and Restated
Certificate of Incorporation, which triggered a right of the Company’s public stockholders to demand the redemption of their
public shares out of funds held in the Company’s trust account. Prior to redemptions, the Company had 17,250,000 public shares
outstanding. Holders of 10,891,882 of the Company’s public shares properly requested redemption, resulting in 6,358,118 public
shares outstanding, and approximately $113 million was paid to the redeeming public stockholders (the
“Redemptions”).
The funds held in the Company’s trust account, including
any interest thereon, will not be used to pay for any excise tax liabilities with respect to any of the redemptions or future redemptions
prior to or in connection with an initial business combination or the liquidation of the Company. The excise tax, when or if it becomes
due, will be paid by the Company.
Business Combination
Following the closing of the IPO and full exercise of the
over-allotment option by the underwriter on December 14, 2021, approximately $174 million ($10.10 per Unit) from the net proceeds of the
sale of the Units in the IPO and the sale of the Private Placement Warrants was deposited into the trust account. After taking into account
the Redemptions described above, there was $68,344,713 available in the trust account as of September 30, 2023.
The Company’s management has broad discretion with
respect to the specific application of the remaining net proceeds of the IPO, although substantially all of the net proceeds of the IPO
are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a target business. As used herein,
“target business” must be with one or more target businesses that together have a fair market value equal to at least 80%
of the balance in the trust account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the
Company’s signing a definitive agreement in connection with a Business Combination. Furthermore, there is no assurance that the
Company will be able to successfully effect a Business Combination.
The Company’s amended and restated certificate of
incorporation allows the Company to extend the Termination Date by up to nine (9) one-month extensions to March 14, 2024. If the Company
is unable to complete the initial Business Combination by the Termination Date (or any Extended Period), the Company will (1) cease all
operations except for the purpose of winding up, (2) as promptly as reasonably possible but not more than ten business days thereafter,
redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders
(including the right to receive further liquidating distributions, if any) and (3) as promptly as reasonably possible following such redemption,
subject to the approval of the Company’s remaining stockholders and the board of directors, dissolve and liquidate, subject in each
case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable
law.
On July 13, 2023, we entered into a Non-Binding Letter of
Intent (“LOI”) with Anteco Systems, S.L., a private limited company incorporated under the laws of Spain (“AnyTech”
and “Target”), pursuant to which we propose to acquire all the issued and outstanding share capital of AnyTech, based on certain
material financial and business terms and conditions being met. On September 8, 2023, we entered into a definitive Business Combination
Agreement and Plan of Merger (the “Business Combination Agreement”) with Millymont Limited, a private limited company incorporated
in Ireland (“Holdco”), AnyTech365 Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Holdco (“Merger
Sub”), J. Streicher Technical Services, LLC, a Delaware limited liability company (“J. Streicher”), AnyTech, Miguel
Ángel Casales Ruiz and Thomas Marco Balsloev, as the Target’s representatives (the “Target’s Representatives”),
and Jaleel Lewis, as the Company’s representative (the “Company Representative”), pursuant to which, among other things,
Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity and a wholly owned subsidiary of
Holdco, and the Target will merge with and into Holdco, with Holdco continuing as the surviving entity, resulting in Holdco becoming the
successor registrant to the Company (the “Transaction”). As of the date of filing of this Quarterly Report, the Business Combination
Agreement had not closed.
Going Concern and Management’s Plans
As of September 30, 2023, the Company had $7,375 in its
operating bank account and adjusted working capital deficit of $2,264,969 (which includes a pending reimbursement from the trust account
for the Company’s franchise taxes and income taxes in the aggregate amount of $1,254,637).
In addition, in order to finance transaction costs in connection
with a Business Combination, the Sponsor, initial stockholders, officers, directors or their affiliates may, but are not obligated to,
provide the Company with Working Capital Loans (as defined below) (see Note 3). As of September 30, 2023, there was an aggregate of $816,400
due to the Sponsor under such Working Capital Loans included within due to related party on the condensed balance sheet. The Company intends
to request additional Working Capital Loans until a Business Combination is consummated.
Management has determined that the possibility that the Company may be
unsuccessful in consummating an initial Business Combination by March 14, 2024 (subject to paying for four additional one-month extensions
as provided above) and thereby be required to cease all operations, redeem the public shares and thereafter liquidate and dissolve, raises
substantial doubt about the ability to continue as a going concern for at least one year from the date the financial statements included
in this Quarterly Report on Form 10-Q were issued. The financial statements do not include any adjustments that might result from the
outcome of this uncertainty. If the Company decides to extend the business combination period by up to six months, then the Company will
need to raise additional capital in order to fund the working capital needs of the Company. The accompanying financial statements have
been prepared in conformity with U.S. GAAP, which contemplate continuation of the Company as a going concern and the realization of assets
and satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the financial
statements do not necessarily purport to represent realizable or settlement values. The financial statements do not include any adjustment
that might result from the outcome of this uncertainty.
Basis of Presentation
The accompanying unaudited condensed financial statements have
been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for
interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete
financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items)
which are considered necessary for a fair presentation of the unaudited condensed financial statements of the Company as of September
30, 2023 and for the three and nine months ended September 30, 2023. The results of operations for the three and nine months ended September
30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. These
unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related
disclosures for the year ended December 31, 2022 which are included in the Annual Report filed on Form 10-K on March 10, 2023.
Note 2 — Significant Accounting Policies
There have been no material changes to the significant accounting
policies included in the audited financial statements as of December 31, 2022 and for the year then ended, which were included the Annual
Report filed on Form 10-K on March 10, 2023, except as disclosed in this note.
Reclassifications
Certain prior period income statement amounts have been reclassified
to conform to the Company’s fiscal 2023 presentation. These reclassifications have no impact on the Company’s previously reported
net loss.
Class A Common Stock Subject to Possible Redemption
The Company accounts for Class A Common Stock subject to possible
redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities
from Equity.” Class A Common Stock subject to mandatory redemption is classified as a liability instrument and is measured at fair
value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control
of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified
in temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A Common
Stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of
uncertain future events. Accordingly, as of September 30, 2023, the 6,358,118 shares of Class A Common Stock are presented at redemption
value of $67,090,078, or $10.55 per share, as temporary equity, outside of the stockholders’ deficit section of the balance sheet.
Convertible Instruments
The
Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as
derivative financial instruments to be separately accounted for in accordance with Topic 815 “Derivatives and Hedging”
(“ASC 815”) of the FASB ASC. The accounting treatment of derivative financial instruments requires that the Company
record any bifurcated embedded features at their fair values as of the inception date of the agreement and at fair value as of each
subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or
expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification
changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the
reclassification. Bifurcated embedded features are recorded at their initial fair values which create additional debt discount to
the host instrument.
Net Income (Loss) Per Common Share
Basic net income (loss) per common share is computed by dividing
net income (loss) by the weighted average number of common shares for the period, excluding shares subject to forfeiture. The Company
has two classes of stock, which are referred to as Class A Common Stock and Class B Common Stock. Earnings and losses are shared pro rata
between the two classes of stock. The Company applies the two-class method in calculating earnings (loss) per share. Remeasurement adjustments
associated with the redeemable Class A Common Stock are excluded from earnings (loss) per share as the redemption value approximates fair
value.
The calculation of diluted net income (loss) per share does
not consider the effect of the warrants issued in connection with the (i) IPO, and (ii) the private placement because the warrants are
contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 14,350,000 shares of Class
A Common Stock in the aggregate. As of September 30, 2023 and December 31, 2022, the Company did not have any dilutive securities or other
contracts that could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company.
As a result, diluted net income (loss) per common share is the same as basic net loss per common share for the periods presented.
| |
For the Three Months Ended | | |
For the Nine Months Ended | |
| |
September 30, 2023 | | |
September 30, 2023 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net income per share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net income | |
$ | 369,825 | | |
$ | 250,840 | | |
$ | 1,858,868 | | |
$ | 590,330 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding including common stock subject to redemption | |
| 6,358,118 | | |
| 4,312,500 | | |
| 13,579,476 | | |
| 4,312,500 | |
Basic and diluted net income per share | |
$ | 0.06 | | |
$ | 0.06 | | |
$ | 0.14 | | |
$ | 0.14 | |
| |
For the Three Months Ended | | |
For the Nine Months Ended | |
| |
September 30, 2022 | | |
September 30, 2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net loss per share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net loss | |
$ | 255,444 | | |
$ | 63,861 | | |
$ | (177,530 | ) | |
$ | (44,382 | ) |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding including common stock subject to redemption | |
| 17,250,000 | | |
| 4,312,500 | | |
| 17,250,000 | | |
| 4,312,500 | |
Basic and diluted net loss per share | |
$ | 0.01 | | |
$ | 0.01 | | |
$ | (0.01 | ) | |
$ | (0.01 | ) |
Income Taxes
The Company follows the asset and liability method of accounting
for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future
tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income
in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute
for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes
accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023, the Company accrued
$18,047 related to estimated tax penalties, of which, $(7,248) and $18,047, was included within formation and operating costs on the statement
of operations for the three and nine months ended September 30, 2023, respectively. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income
tax examinations by major taxing authorities since inception.
At the end of each interim reporting period, the Company determines
the income tax provision by using an estimate of the annual effective tax rate, adjusted for discrete items occurring in the quarter.
The Company’s effective tax rate for the nine months
ended September 30, 2023 was 30%, which differed from the federal statutory tax rate of 21% primarily due to the change in valuation allowance
recognized against deferred tax assets in the U.S.
Judgment is required in determining whether deferred tax assets
will be realized in full or in part. Management assesses the available positive and negative evidence on a jurisdictional basis to estimate
if deferred tax assets will be recognized and when it is more likely than not that all or some deferred tax assets will not be realized,
and a valuation allowance must be established. As of September 30, 2023, the Company’s deferred tax asset had a full valuation allowance
of $569,117.
Recent Accounting Standards
Management does not believe that any recently issued, but not
yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 — Related Party Transactions
Working Capital Loans
In order to finance transaction costs in connection with an
intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors
may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). The Sponsor entered
into a working capital promissory note (“Promissory Note”) with the Company, pursuant to which the Sponsor will make certain
non- interest bearing loans and advances to the Company up to $2,000,000. The principal balance of the Promissory Note will be due and
payable by the Company upon the earlier of: (i) the closing of the initial Business Combination, and (ii) the liquidation of the Company.
If the Company completes an initial Business Combination, the Company will be obligated to repay such loaned amounts out of the proceeds
of the trust account released to the Company. In the event that the initial Business Combination does not close, the Company may use a
portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from the trust account can
be used to repay such loaned amounts. The Company may elect to convert up to $2,000,000 of unpaid principal under the Promissory Note
into that number of warrants, equal to: (i) the portion of the unpaid principal begin converted, divided by (y) the conversion price of
One Dollar ($1.00) per warrant, rounded up to the nearest whole number of warrants. The warrants are identical to the Private Placement
Warrants, including as to exercise price, exercisability, and exercise period.
During the three and nine months ended September 30, 2023, the Sponsor
deposited $450,000 and $600,000, respectively, related to Extension Fees into the trust account on behalf of the Company in the form of
Working Capital Loans. Further, during the three and nine months ended September 30, 2023, the Sponsor made payments to vendors on behalf
of the Company in the amount of $216,400 in the form of Working Capital Loans. As of September 30, 2023, the Company had aggregate Working
Capital Loans outstanding to the Sponsor in the amount of $816,400, which were included in “Due to related party” on the condensed
balance sheet as of such date. See Note 6 – Subsequent Events – Working Capital Loans.
Administrative Services Agreement
We entered into an agreement, commencing on
the effective date of the IPO, to pay the Sponsor $10,000 per month for office space and secretarial and administrative services
provided to members of the Company’s management team. Upon completion of the initial Business Combination or the
Company’s liquidation, the Company will cease paying these monthly fees. During the three and nine months ended September 30,
2023, we recognized $30,000 and $90,000, respectively, of such administrative support services expense. During the three and nine
months ended September 30, 2022, we recognized $30,000 and $90,000, respectively, of such administrative support services expense.
As of September 30, 2023, the Company had accrued $40,000 of administrative support services expense related to the agreement.
Note 4 — Fair Value Measurements
Fair value is defined as the price that would be received
for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date.
GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the
highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest
priority to unobservable inputs (Level 3 measurements). These tiers include:
| ● | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
| ● | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly
observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets
that are not active; and |
| ● | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring
an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs
or significant value drivers are unobservable. |
As of September 30, 2023, the investments
in the Company’s trust account consisted of $0 in cash and $68,344,714 in U.S. Treasury Securities. As of December 31, 2022,
the investments in the Company’s trust account consisted of $247 in cash and $176,146,847 in U.S. Treasury Securities. All of
the U.S. Treasury Securities have maturities of 185 days or less. The Company classifies its United States Treasury securities as
held-to-maturity in accordance with FASB ASC 320 “Investments — Debt and Equity Securities.” Held-to-maturity
treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The
Company considers all investments with original maturities of more than three months but less than one year to be short-term
investments. The carrying value approximates the fair value due to its short-term maturity (Level 1).
The carrying value, excluding gross unrealized holding losses and fair
value of held to maturity securities as of September 30, 2023 and December 31, 2022 are as follows:
September 30, 2023 | |
Amortized Cost and Carrying Value | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value as of September 30, 2023 | |
Cash held in trust | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
U.S. Treasury Securities | |
| 68,344,713 | | |
| — | | |
| — | | |
| 68,344,713 | |
| |
$ | 68,344,713 | | |
$ | — | | |
$ | — | | |
$ | 68,344,713 | |
December 31, 2022 | |
Amortized Cost and Carrying Value | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value as of December 31, 2022 | |
Cash held in trust | |
$ | 247 | | |
$ | — | | |
$ | — | | |
$ | 247 | |
U.S. Treasury Securities | |
| 176,146,847 | | |
| 414,227 | | |
| — | | |
| 176,561,074 | |
| |
$ | 176,147,094 | | |
$ | 414,227 | | |
$ | — | | |
$ | 176,561,322 | |
Note 5 — Commitments and Contingencies
Inflation Reduction Act of 2022 (the “IR
Act”)
On August 16, 2022, the Inflation Reduction Act of 2022 (the
“IR Act”) was signed into federal law. The IR Act provides for, among other things, a new
U.S. federal 1% excise tax on certain repurchases of
stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring
on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares
are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase.
However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new
stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply
to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and
other guidance to carry out and prevent the abuse or avoidance of the excise tax.
Any redemption or other repurchase in connection with
a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be
subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors,
including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise,
(ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection
with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year
of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax
would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been
determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company’s
ability to complete a business combination. Finally, based on recently issued interim guidance from the Internal Revenue Service and Treasury,
subject to certain exceptions, the excise tax should not apply in the event of our liquidation.
In connection with the Company’s Special Meeting on June 12, 2023,
the Company’s stockholders redeemed 10,891,882 shares of Class A Common Stock and approximately $113 million was paid to the redeeming
public stockholders on June 30, 2023. The Company evaluated the current status and probability of completing a Business Combination as
of September 30, 2023 and concluded that it is probable that a contingent liability should be recorded in connection with excise tax payable
upon completion of an initial Business Combination. As of September 30, 2023, the Company recorded an excise tax liability of $1,130,464,
calculated as 1% of the total amount paid to redeeming shareholders in connection with the Special Meeting.
Note 6 — Subsequent Events
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, the Company
did not identify any subsequent events that would have required adjustment or disclosure in the financial statements other than noted
below.
Working Capital Loans
On October 16, 2023, $150,000 was deposited into the
trust account of the Company by the Sponsor for an Extension Fee, which enabled the Company to extend the period of time it has to consummate
its initial business combination by one month from October 14, 2023 to November 14, 2023. The extension was the fifth of nine one-month
extensions permitted under the Company’s governing documents. The payment was made on behalf of the Company in the form of a Working
Capital Loan.
Item 2. Management’s Discussion and Analysis of
Financial Condition and Results of Operations.
References to the “Company,”
“Zalatoris Acquisition Corp.,” “our,” “us” or “we” refer to
Zalatoris Acquisition Corp., references to “management” or “management team” refer to our officers
and directors, and references to the “Sponsor” refer to J. Streicher Holdings, LLC. The following discussion and analysis
of our financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and
the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q (this “Quarterly Report”). Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report includes, and oral statements
made from time to time by our representatives may include, forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and are intended to be covered by the safe harbor created thereby. The Company has based these forward-looking statements
on management’s current expectations, projections and forecasts about future events. These forward-looking statements are subject
to known and unknown risks, uncertainties and assumptions about us that may cause our actual business, financial condition, results of
operations, performance and/or achievements to be materially different from any future business, financial condition, results of operations,
performance and/or achievements expressed or implied by these forward-looking statements. Factors that might cause or contribute to such
a discrepancy include, but are not limited to, those described in our other filings with the SEC. The words “anticipate,”
“believe,” “continue,” “could,” “estimate,” “expect,” “intends,”
“may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,”
“target,” “goal,” “shall,” “should,” “will,” “would” and similar
expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
In addition, any statements that refer to expectations, projections, forecasts or other characterizations of future events or circumstances,
including any underlying assumptions, are forward-looking statements.
Overview
We are a blank check company incorporated as a Delaware
corporation and formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination with one or more businesses or entities. We intend to effectuate our initial business combination
using cash from the proceeds of our initial public offering (the “IPO”) and the sale of the Private Placement Warrants (as
defined below), our capital stock, debt or a combination of cash, stock and debt.
On December 14, 2021, we consummated the IPO of 17,250,000
units (the “Units”), including the issuance of 2,250,000 Units as a result of the underwriters’ exercise of their over-allotment
option in full. Each Unit consists of one share of our Class A common stock, par value $0.0001 per share (the “Class A Common Stock”),
and one-half of one of our redeemable public warrants (each whole warrant, a “Public Warrant”), with each whole Public Warrant
entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, subject to adjustment. The Units were
sold at a price of $10.00 per Unit, generating gross proceeds of $172,500,000.
On December 14, 2021, simultaneously with the consummation
of the IPO, we completed the private sale (the “Private Placement”) of an aggregate of 5,725,000 warrants (the “Private
Placement Warrants”) to Trajectory Alpha Sponsor LLC, our former sponsor (the “Former Sponsor”), at a purchase price
of $1.00 per Private Placement Warrant, generating gross proceeds of $5,725,000.
The net proceeds from the IPO, together with certain
of the proceeds from the Private Placement, $174,225,000 in the aggregate (the “Offering Proceeds”), were placed in a U.S.-based
trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
Transaction costs amounted to $22,323,737, consisting
of $1,500,000 of cash underwriting commissions, $5,366,378 of fair value shares of Class B common stock, par value $0.0001 per share (the
“Class B Common Stock”), issued to the underwriter, $6,262,500 of deferred underwriting commissions, $8,658,646 of the excess
of fair value of the shares of Class B Common Stock acquired by Anchor Investors, and $536,213 of other offering costs.
As of September 30, 2023, the Company had $7,375 in
its operating bank account and adjusted working capital deficit of $2,264,969 (which includes a pending reimbursement from the trust account
for the Company’s franchise taxes and income taxes in the aggregate amount of $1,254,637). Further, we expect to continue to incur
significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to raise capital or to complete our initial
business combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated
any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for the IPO.
Following the IPO, we have not generated any operating revenues and will not generate any operating revenues until after completion of
our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents. There
has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our
financial statements. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing
compliance), as well as expenses as we conduct due diligence on prospective business combination candidates.
For the three months ended September 30, 2023, we had
net income of $620,665 which consisted of $1,586,599 of interest income, partially offset by formation and operating costs of $104,260,
professional fees of $447,241, franchise tax expense of $50,000 and income tax expense of $364,433. For the nine months ended September
30, 2023, we had net income of $2,449,198 which consisted of $5,109,166 of interest income, partially offset by formation and operating
costs of $592,601, professional fees of $861,229, franchise tax expense of $150,000 and income tax expense of $1,056,138.
For the three months ended September 30, 2022, we had net income of $319,305,
which consisted of $685,599 of interest income and an income tax benefit of $41,929, all partially offset by formation and operating costs
of $358,223 and franchise tax expense of $50,000. For the nine months ended September 30, 2022, we had net loss of $221,912, which consisted
of formation and operating costs of $901,080 and franchise tax expense of $150,000, partially offset by $787,239 of interest income and
an income tax benefit of $41,929.
Change in Sponsor
On June 2, 2023, we entered into a Purchase and Contribution
Agreement (the “Purchase Agreement”) with J. Streicher Holdings, LLC (the “Sponsor”) and Trajectory Alpha Sponsor
LLC (“Former Sponsor”), pursuant to which the Sponsor purchased 2,170,464 shares of Class B Common Stock and 4,525,000 Private
Placement Warrants from the Former Sponsor.
In addition, on June 2, 2023, we entered into a Purchase
Agreement (the “Metric Assignment”) with J. Streicher Holdings, LLC (the “Sponsor”), the Trajectory Alpha Sponsor
LLC (the “Former Sponsor”), and Metric Finance Holdings II, LLC (“Metric”), pursuant to which the Sponsor acquired
422,434 shares of Class B Common Stock from Metric.
Accordingly, the Sponsor now holds 2,592,898 shares out
of the 4,312,500 issued and outstanding shares of Class B Common Stock and 4,525,000 Private Placement Warrants out of the 5,725,000 issued
and outstanding Private Placement Warrants.
Proposed Business Combination
On July 13, 2023, we entered into
a Non-Binding Letter of Intent (“LOI”) with Anteco Systems, S.L., a private limited company incorporated under the laws of
Spain (“AnyTech” and “Target”), pursuant to which we propose to acquire all the issued and outstanding share capital
of AnyTech, based on certain material financial and business terms and conditions being met. On September 8, 2023, we entered into a definitive
Business Combination Agreement and Plan of Merger (the “Business Combination Agreement”) with Millymont Limited, a private
limited company incorporated in Ireland (“Holdco”), AnyTech365 Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary
of Holdco (“Merger Sub”), J. Streicher Technical Services, LLC, a Delaware limited liability company (“J. Streicher”),
AnyTech, Miguel Ángel Casales Ruiz and Thomas Marco Balsloev, as the Target’s representatives (the “Target’s
Representatives”), and Jaleel Lewis, as the Company’s representative (the “Company Representative”), pursuant
to which, among other things, Merger Sub will merge with and into the Company, with the Company continuing as the surviving entity and
a wholly owned subsidiary of Holdco, and the Target will merge with and into Holdco, with Holdco continuing as the surviving entity, resulting
in Holdco becoming the successor registrant to the Company (the “Transaction”). As of the date of filing of this Quarterly
Report, the Business Combination Agreement had not closed.
Change of Name
On June 26, 2023, our board of directors filed a certificate
of amendment to the amended and restated certificate of incorporation with the Secretary of State of Delaware, pursuant to which our name
was changed from “Trajectory Alpha Acquisition Corp.” to “Zalatoris Acquisition Corp.” (the “Name Change”).
This Name Change became effective as of the filing date. Trading under the new name began on June 27, 2023.
Extension Amendment to Amended and Restated Certificate
of Incorporation
On June 12, 2023, at a special meeting of our stockholders
(the “Special Meeting”), our stockholders approved an amendment (the “Charter Amendment”) to our amended and restated
certificate of incorporation, which amended the structure and cost of our right to extend the date (the “Termination Date”)
by which we must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination involving our business and one or more businesses, (ii) cease our operations if we fail to complete such Business Combination,
and (iii) redeem or repurchase 100% of our Class A Common Stock included as part of the units sold in our initial public offering.
The Charter Amendment allows us to extend the Termination Date by up to
nine one-month extensions to March 14, 2024 (each one-month extension period, an “Extended Period”) provided that if any Extended
Period ends on a day that is not a business day, such Extended Period will be automatically extended to the next succeeding business day.
To obtain each one-month extension, the Company, the Sponsor, or any of our affiliates or designees must deposit into our trust account
by the deadline applicable prior to the extension the lesser of (i) $150,000 and (ii) an aggregate amount equal to $0.04 multiplied by
the number of our public shares that were not redeemed in connection with the stockholder vote at the Special Meeting (the “Extension
Fee”). To date, we have caused an aggregate of $750,000 to be deposited into the trust account for the five of the nine monthly
extensions such that the current termination date of the Company is November 14, 2023.
Liquidity and Capital Resources
As of September 30, 2023, the Company had $7,375 in its
operating bank account and adjusted working capital deficit of $2,264,969 (which includes a pending reimbursement from the trust account
for the Company’s franchise taxes and income taxes in the aggregate amount of $1,254,637).
Management has determined that the possibility that we
may be unsuccessful in consummating an initial Business Combination by March 14, 2024 (subject to paying for four additional one-month
extensions as provided above) and thereby be required to cease all operations, redeem the public shares and thereafter liquidate and dissolve,
raises substantial doubt about the ability to continue as a going concern for at least one year from the date the financial statements
included in this Quarterly Report on Form 10-Q were issued. The financial statements do not include any adjustments that might result
from the outcome of this uncertainty. If we decide to extend the business combination period by up to six months, then we will need to
raise additional capital in order to fund our working capital needs. The accompanying financial statements have been prepared in conformity
with U.S. GAAP, which contemplate our continuation as a going concern and the realization of assets and satisfaction of liabilities in
the normal course of business. The carrying amounts of assets and liabilities presented in the financial statements do not necessarily
purport to represent realizable or settlement values. The financial statements do not include any adjustment that might result from the
outcome of this uncertainty.
Off-Balance Sheet Financing Arrangements
As of September 30, 2023 and December 31, 2022, we did not
have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Commitments and Contractual Obligations
Other than the below, we do not have any long-term debt obligations,
capital lease obligations, operating lease obligations, purchase obligations or long- term liabilities.
Administrative Services Agreement
We entered into an agreement, commencing on the effective
date of the IPO, to pay the Sponsor $10,000 per month for office space and secretarial and administrative services provided to members
of our management team. Upon completion of the initial Business Combination or our liquidation, we will cease paying these monthly fees.
During the three and nine months ended September 30, 2023, we recognized $30,000 and $90,000, respectively, of such administrative support
services expense. During the three and nine months ended September 30, 2022, we recognized $30,000 and $90,000, respectively, of such
administrative support services expense. As of September 30, 2023, we had accrued $40,000 of administrative support services expense related
to the agreement.
Registration and Stockholder Rights
The holders of the Class B Common Stock, Private Placement
Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise
of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Class B Common
Stock) are entitled to registration rights pursuant to a registration rights agreement entered into on the effective date of the IPO requiring
us to register such securities for resale (in the case of the Class B Common Stock, only after conversion to shares of Class A Common
Stock). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that
we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration
statements filed subsequent our completion of the initial Business Combination and rights to require us to register for resale such securities
pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that no sales of these securities will
be effected until after the expiration of the applicable lock-up period, as described herein. We will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriting Agreement
The underwriter had a 45-day option from the date of
the IPO to purchase up to an additional 2,250,000 Units to cover over-allotments. On December 14, 2021, the underwriter fully exercised
its over-allotment option.
The underwriter was paid an underwriting commission of
$0.10 per unit, or $1,500,000 in the aggregate, upon the closing of the IPO. The underwriter was also issued 662,434 shares of Class B
Common Stock (as defined below) with a fair value of $5,366,378, or $8.10 per share. We valued those shares using a Black-Scholes Model.
In addition, $6,262,500 is payable to the underwriter for deferred underwriting commissions. The deferred underwriting commission will
become payable to the underwriter from the amounts held in the trust account solely in the event that we complete the Business Combination,
subject to the terms of the underwriting agreement.
The underwriters have agreed (i) to waive their conversion
rights (or right to participate in any tender offer) with respect to such shares in connection with the initial business combination and
(ii) to waive their rights to liquidating distributions from the trust account with respect to such shares if we fail to complete the
initial business combination within the completion window.
The Class B Common Stock received by the underwriter has
been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110(e)(1). Additionally, these
Class B Common Stock may not be sold, transferred, assigned, pledged or hypothecated or be the subject of any hedging, short sale, derivative,
put or call transaction that would result in the economic disposition of the securities by any person for a 180-day period following the
effective date of this prospectus except to any selected dealer participating in the offering and the bona fide officers or partners of
the underwriter and any such participating selected dealer. The underwriter has agreed that the Class B Common Stock they receive will
not be sold or transferred by them (except to certain permitted transferees) until after we completed an initial Business Combination.
We granted the holders of Class B Common Stock the registration rights. In compliance with FINRA Rule 5110, the underwriter’s registration
rights are limited to demand and “piggy back” rights for periods of five and seven years, respectively, from the effective
date of this prospectus with respect to the registration under the Securities Act of the Class B Common Stock.
Critical Accounting Policies and Estimates
The preparation of the financial statement in conformity
with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the date of the financial statement.
Making estimates requires management to exercise significant
judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed
at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to
one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. We have identified
the following as our critical accounting policies:
Class A Common Stock Subject to Possible Redemption
We account for our Class A Common Stock subject to possible redemption
in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from
Equity.” Class A Common Stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value.
Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified in temporary equity.
At all other times, common stock is classified as stockholders’ equity. Our Class A Common Stock feature certain redemption rights
that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, as of September 30,
2023, the 6,358,118 shares of Class A Common Stock are presented at redemption value of $67,090,078 or $10.55 per share, as temporary
equity, outside of the stockholders’ deficit section of the balance sheet.
Working Capital Loans
In order to finance transaction costs in connection
with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the our officers and directors
may, but are not obligated to, loan the us funds as may be required (the “Working Capital Loans”). The Sponsor entered into
a working capital promissory note (“Promissory Note”) with us, pursuant to which the Sponsor will make certain non- interest
bearing loans and advances to us up to $2,000,000. The principal balance of the Promissory Note will be due and payable by us upon the
earlier of: (i) the closing of the initial Business Combination, and (ii) the liquidation of the Company. If we complete an initial Business
Combination, we will be obligated to repay such loaned amounts out of the proceeds of the trust account released to us. In the event that
the initial Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such
loaned amounts but no proceeds from the trust account can be used to repay such loaned amounts. We may elect to convert up to $2,000,000
of unpaid principal under the Promissory Note into that number of warrants, equal to: (i) the portion of the unpaid principal begin converted,
divided by (y) the conversion price of One Dollar ($1.00) per warrant, rounded up to the nearest whole number of warrants. The warrants
are identical to the Private Placement Warrants, including as to exercise price, exercisability, and exercise period.
During the three and nine months ended September
30, 2023, the Sponsor deposited $450,000 and $600,000, respectively, related to Extension Fees into the trust account on behalf of the
Company in the form of Working Capital Loans. Further, during the three and nine months ended September 30, 2023, the Sponsor made payments
to vendors on behalf of the Company in the amount of $216,400 in the form of Working Capital Loans. As of September 30, 2023, the Company
had aggregate Working Capital Loans outstanding to the Sponsor in the amount of $816,400, which were included in “Due to related
party” on the condensed balance sheet as of such date.
Income Taxes
We follow the asset and liability method of accounting
for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future
tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and
their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income
in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities
of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established,
when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute
for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits
to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. As of September
30, 2023, we accrued $18,047 related to estimated tax penalties, of which, $(7,248) and $18,047, was included within formation and operating
costs on the statement of operations for the three and nine months ended September 30, 2023, respectively. We are currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from our position. We are subject
to income tax examinations by major taxing authorities since inception. related to estimated tax penalties, which was included within
formation and operating costs on the statement of operations for the nine months ended September 30, 2023. We are currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from our position. We are subject
to income tax examinations by major taxing authorities since inception.
At the end of each interim reporting period, we determine
the income tax provision by using an estimate of the annual effective tax rate, adjusted for discrete items occurring in the quarter.
Our effective tax rate for the nine months ended September
30, 2023 was 30%, which differed from the federal statutory tax rate of 21% primarily due to the change in valuation allowance recognized
against deferred tax assets in the U.S.
Judgment is required in determining whether deferred tax
assets will be realized in full or in part. Management assesses the available positive and negative evidence on a jurisdictional basis
to estimate if deferred tax assets will be recognized and when it is more likely than not that all or some deferred tax assets will not
be realized, and a valuation allowance must be established. As of September 30, 2023, our deferred tax asset had a full valuation allowance
of $569,117.
Net Loss per Common Share
We comply with accounting and disclosure requirements
of FASB ASC Topic 260, “Earnings Per Share”. Net loss per common share is computed by dividing net loss by the weighted average
number of shares of common stock for the period. We have two classes of stock, which are referred to as Class A Common Stock and Class
B Common Stock. Earnings and losses are shared pro rata between the two classes of stock. We apply the two-class method in calculating
earnings per share. Remeasurement adjustments associated with the redeemable Class A Common Stock are excluded from earnings per share
as the redemption value approximates fair value.
The calculation of diluted loss per share does not
consider the effect of the warrants issued in connection with the (i) IPO, and (ii) the private placement because the warrants are contingently
exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 14,350,000 Class A Common Stock in
the aggregate. As of September 30, 2023 and December 31, 2022, we did not have any dilutive securities or other contracts that could,
potentially, be exercised or converted into common stock and then share in our earnings. As a result, diluted net loss per common share
is the same as basic net loss per common share for the periods presented.
Recent Accounting Pronouncements
Management does not believe that any recently issued,
but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial statements.
Item 3. Quantitative and Qualitative Disclosure About Market Risk
Not applicable to smaller reporting companies.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are controls and other procedures
that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded,
processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures
include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed
or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer (who serves as
our Principal Executive Officer) and Chief Financial Officer (who serves as our Principal Financial and Accounting Officer), as appropriate,
to allow timely decisions regarding required disclosure.
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our
Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our
disclosure controls and procedures as of September 30, 2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were
effective as of September 30, 2023.
Changes in Internal Control over Financial Reporting
Except as described above, there were no changes in our internal control
over financial reporting during the quarter ending September 30, 2023 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Management recognizes that a control system, no matter how well conceived
and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design
of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative
to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that
judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls
can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls.
The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can
be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls
may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because
of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
PART II-OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
Factors that could cause our actual business, financial condition and/or
results of operations to differ materially from those in this Quarterly Report are any of the risks factors described in our final prospectus
dated December 9, 2021 filed with the SEC on December 13, 2021 (the “IPO Prospectus”) and our Annual Report on Form 10-K for
the year ended December 31, 2022 filed with the SEC on March 10, 2023 (the “Form 10-K”). Any of these risk factors could result
in a significant or material adverse effect on our business, financial condition and/or results of operations. Additional risk factors
not presently known to us or that we currently deem to be immaterial may also impair our business, financial condition, and/or results
of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in the IPO Prospectus
or the Form 10-K.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds,
and Issuer Purchases of Equity Securities.
There were no unregistered sales of equity securities during the nine
months ended September 30, 2023.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
Item 6. Exhibits
No. |
|
Description of Exhibit |
|
|
2.1 |
|
Business Combination Agreement dated September 8, 2023 (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 8, 2023). |
|
|
|
3.1 |
|
Amended and Restated Certificate of Incorporation of Zalatoris Acquisition Corp. (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on December 15, 2021). |
|
|
|
3.2 |
|
Amendment to the Amended and Restated Certificate of Incorporation of Zalatoris Acquisition Corp. (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on June 15, 2023). |
|
|
|
10.1 |
|
Stockholder Support Agreement dated September 8, 2023 (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on September 8, 2023). |
|
|
31.1* |
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
31.2* |
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32.1** |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
32.2** |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
|
101.INS* |
|
Inline XBRL Instance Document-the instance document does not appear
in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
|
|
101.SCH* |
|
Inline XBRL Taxonomy Extension Schema Document |
|
|
101.CAL* |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
101.DEF* |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
|
|
101.LAB* |
|
Inline XBRL Taxonomy Extension Labels Linkbase Document |
|
|
101.PRE* |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
104 |
|
Cover Page Interactive Data File-The cover page interactive data file
does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| ** | These certifications are furnished
to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended, and are deemed not filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities
Act, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
|
ZALATORIS ACQUISITION CORP. |
|
|
|
Date: November 13, 2023 |
By: |
/s/ Paul Davis |
|
Name: |
Paul Davis |
|
Title: |
Chief Executive Officer
(Principal Executive Officer) |
|
|
|
Date: November 13, 2023 |
By: |
/s/ Pantelis Dimitriou |
|
Name: |
Pantelis Dimitriou |
|
Title: |
Chief Financial Officer
(Principal Financial and Accounting Officer) |
22
13579476
17250000
17250000
6358118
0.01
0.01
0.06
0.14
4312500
4312500
4312500
4312500
0.01
0.01
0.06
0.14
0.06
0.06
0.14
0.14
0.01
0.01
0.01
0.01
false
--12-31
Q3
0001846750
0001846750
2023-01-01
2023-09-30
0001846750
tcoa:UnitsEachConsistingOfOneShareOfClassACommonStockAndOnehalfOfOneRedeemablePublicWarrantMember
2023-01-01
2023-09-30
0001846750
tcoa:ClassACommonStockParValue00001PerShareMember
2023-01-01
2023-09-30
0001846750
tcoa:RedeemablePublicWarrantsEachRedeemablePublicWholeWarrantExercisableForOneShareOfClassACommonStockAtAnExercisePriceOf1150PerWholeSharesMember
2023-01-01
2023-09-30
0001846750
us-gaap:CommonClassAMember
2023-11-09
0001846750
us-gaap:CommonClassBMember
2023-11-09
0001846750
2023-09-30
0001846750
2022-12-31
0001846750
us-gaap:RelatedPartyMember
2023-09-30
0001846750
us-gaap:RelatedPartyMember
2022-12-31
0001846750
us-gaap:CommonClassAMember
2023-09-30
0001846750
us-gaap:CommonClassAMember
2022-12-31
0001846750
us-gaap:CommonClassBMember
2023-09-30
0001846750
us-gaap:CommonClassBMember
2022-12-31
0001846750
2023-07-01
2023-09-30
0001846750
2022-07-01
2022-09-30
0001846750
2022-01-01
2022-09-30
0001846750
us-gaap:CommonClassAMember
2023-07-01
2023-09-30
0001846750
us-gaap:CommonClassAMember
2022-07-01
2022-09-30
0001846750
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001846750
us-gaap:CommonClassAMember
2022-01-01
2022-09-30
0001846750
us-gaap:CommonClassBMember
2023-07-01
2023-09-30
0001846750
us-gaap:CommonClassBMember
2022-07-01
2022-09-30
0001846750
us-gaap:CommonClassBMember
2023-01-01
2023-09-30
0001846750
us-gaap:CommonClassBMember
2022-01-01
2022-09-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-12-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-01-01
2023-03-31
0001846750
2023-01-01
2023-03-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-03-31
0001846750
2023-03-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-04-01
2023-06-30
0001846750
2023-04-01
2023-06-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-06-30
0001846750
2023-06-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-07-01
2023-09-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2023-09-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2021-12-31
0001846750
2021-12-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-01-01
2022-03-31
0001846750
2022-01-01
2022-03-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-03-31
0001846750
2022-03-31
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-04-01
2022-06-30
0001846750
2022-04-01
2022-06-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-06-30
0001846750
2022-06-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-07-01
2022-09-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0001846750
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-09-30
0001846750
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0001846750
us-gaap:RetainedEarningsUnappropriatedMember
2022-09-30
0001846750
2022-09-30
0001846750
us-gaap:IPOMember
2021-12-14
2021-12-14
0001846750
us-gaap:IPOMember
2021-12-14
0001846750
us-gaap:OverAllotmentOptionMember
2021-12-14
2021-12-14
0001846750
us-gaap:CommonClassAMember
2021-12-14
0001846750
tcoa:PrivatePlacementWarrantMember
tcoa:SponsorMember
2023-09-30
0001846750
tcoa:PurchaseAndContributionAgreementMember
2023-06-02
2023-06-02
0001846750
tcoa:PurchaseAndContributionAgreementMember
2023-06-02
0001846750
tcoa:PurchaseAndContributionAgreementMember
us-gaap:CommonClassBMember
2023-06-02
2023-06-02
0001846750
tcoa:PurchaseAndContributionAgreementMember
tcoa:PrivatePlacementWarrantMember
2023-06-02
2023-06-02
0001846750
tcoa:MetricFinanceHoldingsIILLCMember
tcoa:SponsorMember
us-gaap:CommonClassBMember
2023-06-02
2023-06-02
0001846750
tcoa:SponsorMember
us-gaap:CommonClassBMember
2023-09-30
0001846750
tcoa:PrivatePlacementWarrantMember
2023-09-30
0001846750
tcoa:ExtensionAmendmentAgreementMember
2023-06-12
0001846750
tcoa:ExtensionAmendmentAgreementMember
2023-09-30
0001846750
us-gaap:IPOMember
2023-01-01
2023-09-30
0001846750
us-gaap:CommonClassAMember
2023-06-12
2023-06-12
0001846750
us-gaap:CommonClassAMember
2023-06-12
0001846750
us-gaap:RelatedPartyMember
2023-01-01
2023-09-30
0001846750
tcoa:PromissoryNoteMember
tcoa:WorkingCapitalLoansMember
tcoa:SponsorMember
2023-09-30
0001846750
tcoa:WorkingCapitalLoansMember
tcoa:SponsorMember
2023-09-30
0001846750
tcoa:SponsorMember
2023-07-01
2023-09-30
0001846750
tcoa:SponsorMember
2023-01-01
2023-09-30
0001846750
tcoa:AdministrativeServicesAgreementMember
tcoa:SponsorMember
2023-01-01
2023-09-30
0001846750
tcoa:AdministrativeServicesAgreementMember
tcoa:SponsorMember
2023-07-01
2023-09-30
0001846750
tcoa:AdministrativeServicesAgreementMember
tcoa:SponsorMember
2022-07-01
2022-09-30
0001846750
tcoa:AdministrativeServicesAgreementMember
tcoa:SponsorMember
2022-01-01
2022-09-30
0001846750
us-gaap:USTreasurySecuritiesMember
2023-09-30
0001846750
us-gaap:USTreasurySecuritiesMember
2022-12-31
0001846750
tcoa:AssetsHeldInTrustMember
2023-09-30
0001846750
tcoa:AssetsHeldInTrustMember
2023-01-01
2023-09-30
0001846750
us-gaap:USTreasurySecuritiesMember
2023-01-01
2023-09-30
0001846750
tcoa:AssetsHeldInTrustMember
2022-12-31
0001846750
tcoa:AssetsHeldInTrustMember
2022-01-01
2022-12-31
0001846750
us-gaap:USTreasurySecuritiesMember
2022-01-01
2022-12-31
0001846750
2022-01-01
2022-12-31
0001846750
tcoa:InflationReductionActOfTwoThousandAndTwentyTwoMember
2023-01-01
2023-01-01
0001846750
tcoa:InflationReductionActOfTwoThousandAndTwentyTwoMember
2023-01-01
2023-09-30
0001846750
us-gaap:CommonClassAMember
2023-06-01
2023-06-12
0001846750
tcoa:WorkingCapitalLoansMember
tcoa:SponsorMember
us-gaap:SubsequentEventMember
2023-10-16
2023-10-16
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly
Report of Zalatoris Acquisition Corp. (the “Registrant”) on Form 10-Q for the quarter ended September 30, 2023 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Davis, Chief Executive Officer, certify
to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
In connection with the Quarterly
Report of Zalatoris Acquisition Corp. (the “Registrant”) on Form 10-Q for the quarter ended September 30, 2023 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I, Pantelis Dimitriou, Chief Financial Officer,
certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002,
that: